Cor Vasa 2006, 48(1):K3

Doporučení pro diagnostiku a léčbu akutního srdečního selhání

1 Interní-kardiologická klinika, Fakultní nemocnice Brno-Bohunice, Brno
2 Kardiologická klinika, Fakultní nemocnice Motol
3 Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, Česká republika

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doporučení pro diagnostiku a léčbu akutního srdečního selhání. Cor Vasa. 2006;48(1):K3.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. ACCP Consensus Committee on Pulmonary Embolism. Opinions regarding the diagnosis and management of venous thromboembolic disease. Chest 1998;113:499-504. Go to original source... Go to PubMed...
    2. Adams KF, Jr, Zannad F. Clinical definition and epidemiology of advanced heart failure. Am Heart J 1998; 135:S204-S215. Go to original source... Go to PubMed...
    3. Al-Khadra AS, Salem DN, Rand WM, et al. Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol 1998;31:749-53. Go to original source... Go to PubMed...
    4. Alpert JS. The thrombosed prosthetic valve: current recommendations based on evidence from the literature. J Am Coll Cardiol 2003;41:659-60. Go to original source... Go to PubMed...
    5. Amiodarone Trials Meta-Analysis Investigators: Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6 500 patients in randomised trials. Lancet 1997;350:1417-24.
    6. Anand IS, Chugh SS, Mechanisms and management of renal dysfunction in heart failure. Curr Opin Cardiol 1997;12:251-8. Go to original source... Go to PubMed...
    7. Angeja BG, Grossmen W. Evaluation and management of diastolic heart failure. Circulation 2003;107:659-63. Go to original source... Go to PubMed...
    8. ANZICS Clinical Trials Group. Low-dose dopamine in patients with early renal dysfunction: a placebo controlled randomised trial. Lancet 2000;356:2139-43. Go to original source... Go to PubMed...
    9. Arnold JM, Braunwald E, Sandor T, et al. Inotropic stimulation of reperfuzed myocardium with dopamine: effects on infarct size and myocardial function. J Am Coll Cardiol 1985;6:1026-34. Go to original source... Go to PubMed...
    10. Ashton CM, Kuykendall DH, Johnson ML, et al. The association between the quality of inpatient care and early readmission. Ann Intern Med 1995;122:415-21. Go to original source... Go to PubMed...
    11. Balcl C, Sungurtekin H, Guerses E, et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Critical Care 2003;7:85-90. Go to original source... Go to PubMed...
    12. Bartlett RH, Roloff DW, Custer JR, et al. Extracorporeal life support: the University of Michigan experience. JAMA 2000;283:904-8. Go to original source... Go to PubMed...
    13. Bellomo R, et al. Continuous haemofiltration in the intensive care unit. Crit Care 2000;4:339-45. Go to original source... Go to PubMed...
    14. Berry C, Mudroch DR, McMurray J. Economics of chronic heart failure. Eur J Heart Fail 2001;3:283-91. Go to original source... Go to PubMed...
    15. Bersten AD, Holt AW, Vedig AE, et al. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med 1991;325:1825-30. Go to original source... Go to PubMed...
    16. Bolli R. Basic and clinical aspects of myocardial stunning. Prog Cardiovasc Dis 1998;40:477-516. Go to original source... Go to PubMed...
    17. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure: The studies of left ventricular dysfunction (SOLVD) Investigators. J Am Coll Cardiol 1993;22 (Suppl. A):14A-19A. Go to original source... Go to PubMed...
    18. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002;40:298-303. Go to original source... Go to PubMed...
    19. Burger AJ, Elkayam U, Neibaur MT, et al. Comparison of the occurrence of ventricular arrhythmias in patiens with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol 2001;88:35-9. Go to original source... Go to PubMed...
    20. Burghoff D, Maurer MS, Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 2003;107:656-8. Go to original source... Go to PubMed...
    21. Cleland JGF, McGowan J. Levosimendan: a new era for inodilator therapy for heart failure? Curr Opin Cardiol 2002;17:257-65. Go to original source... Go to PubMed...
    22. Cleland JGF, Swedberg K, Follath F, et al. The Euro Heart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003;24:442-63. Go to original source... Go to PubMed...
    23. Colucci WS, Denniss AR, Leatherman GF, et al. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition. J Clin Invest 1988;81:1103-10. Go to original source... Go to PubMed...
    24. Colucci WS, Wright RF, Braunwald E. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. N Engl J Med 1986;314:290-9. Go to original source... Go to PubMed...
    25. Colucci WS, Wright RF, Jaski BE, et al. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Circulation 1986;73:III175-III183.
    26. Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbidedinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998;351:389-93. Go to original source... Go to PubMed...
    27. Cotter G, Weissgarten J, Metzkor E, et al. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther 1997;62:187-93. Go to original source... Go to PubMed...
    28. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-25. Go to original source... Go to PubMed...
    29. Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000;101:27-32. Go to original source... Go to PubMed...
    30. Cuffe MS, Califf RM, Adams KF Jr, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002;287:1541-7. Go to original source... Go to PubMed...
    31. Dalrymple-Hay MJ, Monro JL, Livesey SA, et al. Postinfarction ventricular septal rupture: the Wessex experience. Semin Thorac Cardiovasc Surg 1998;10:111-116. Go to original source... Go to PubMed...
    32. Deja MA, Szostek J, Widenka K, et al. Post infarction ventricular septal defect - can we do better? Eur J Cardiothorac Surg 2000;18:194-201. Go to original source... Go to PubMed...
    33. Delgado DH, Rao V, Ross HJ, et al. Mechanical circulatory assistance: state of art. Circulation 2002;106: 2046-50. Go to original source... Go to PubMed...
    34. Delle Karth G, Buberl A, Geppert A, et al. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand 2003;47:1251-6. Go to original source... Go to PubMed...
    35. Ellison KE, Stevenson WG, Sweeney MO, et al. Catheter ablation for hemodynamically unstable monomorphic ventricular tachycardia. J Cardiovasc Electrophysiol 2000;11:41-4. Go to original source... Go to PubMed...
    36. Erbel R, Alfonso F, Boileau C, et al. Diagnosis and management of aortic dissection. Eur Heart J 2001; 22:1642-81. Go to original source... Go to PubMed...
    37. Felker GM, Benza RL, Chandler AB, et al. Heart failure etiology and response to milrinone in decompensated heart failure. Results from the OPTIME-CHF Study. J Am Coll Cardiol 2003;41:997-1003. Go to original source... Go to PubMed...
    38. Follath F, Cleland JGF, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial. Lancet 2002;360:196-202. Go to original source... Go to PubMed...
    39. Forrester JS, Diamond GA, Swan HJ. Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol 1977;39: 137-45. Go to original source... Go to PubMed...
    40. Fowler MB, Laser JA, Hopkins GL, et al. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986;74:1290-302. Go to original source... Go to PubMed...
    41. Fox KF, Cowie MR, Wood DA, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001;22:228-36. Go to original source... Go to PubMed...
    42. Furberg CD. Overview of completed sudden death trials: US experience. Cardiology 1987;74 (Suppl 2):24-31. Go to original source... Go to PubMed...
    43. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001;22:1852-923. Go to original source... Go to PubMed...
    44. Gilbert EM, Hershberger RE, Wiechmann RJ, et al. Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart. Chest 1995;108:1524-32. Go to original source... Go to PubMed...
    45. Goldberg LI, McDonald RH, Jr, Zimmerman AM. Sodium diuresis produced by dopamine in patients with congestive heart failure. N Engl J Med 1963;269:1060-4. Go to original source... Go to PubMed...
    46. Gore JM, Goldberg RJ, Spodick DH, et al. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest 1987;92:721-7. Go to original source... Go to PubMed...
    47. Grady KL, Dracub K, Kennedy G, Moser DK, Piano M, Stevenson LW. AHA Scientific Statement: Team management of patients with heart failure: a statement of health care professional from the cardiovascular nursing council of the American Heart Association. Circulation 2000;1002:2443-56. Go to original source... Go to PubMed...
    48. Held PH, Corbeij HM, Dunselman P, et al. Hemodynamic effects of metoprolol in acute myocardial infarction. A randomized, placebo controlled multicenter study. Am J Cardiol 1985;56:47G-54G. Go to original source... Go to PubMed...
    49. Herlitz J, Elmfeldt D, Hjalmarson A, et al. Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction. Am J Cardiol 1983;51:1282-8. Go to original source... Go to PubMed...
    50. Herlitz J, Waagstein F, Lindqvist J, et al. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Goteborg Metoprolol Trial). Am J Cardiol 1997;80:40J-44J. Go to original source... Go to PubMed...
    51. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-10. Go to original source... Go to PubMed...
    52. Hochman JS, Boland J, Sleeper LA, et al. for the SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation 1995;91:873-81. Go to original source... Go to PubMed...
    53. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction-etiologies, management, and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000;36:1063-70. Go to original source... Go to PubMed...
    54. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med 1999;131:47-59. Go to original source... Go to PubMed...
    55. Chu VL, Cheng JW. Fenoldopam in the prevention of contrast media induced acute renal failure. Ann Pharmacother 2001;35:1278-82. Go to original source... Go to PubMed...
    56. Innes CA, Wagstaff AJ. Levosimendan: A review of its use in the management of acute decompensated heart failure. Drugs 2003;63:2651-71. Go to original source... Go to PubMed...
    57. Investigators VMAC. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure; a randomized controlled trial. Publication committee for the VMAC (Vazodilation in the Management of Acute CHF) Investigators. JAMA 2002;287:1531-40. Go to original source...
    58. Ivanov R, Allen J, Calvin JE. The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: a meta-analysis. Crit Care Med 2000;28:615-9. Go to original source... Go to PubMed...
    59. Janoušek S. Levosimendan na postupu v léčbě srdečního selhání. Cor Vasa 2004;46:597-600.
    60. Katz AM. Potential deleterious effect of inotropic agents in the therapy of chronic heart failure. Circulation 1986;73:III84-III90.
    61. Kelly CA, Newby DE, McDonagh TA, et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. Effects on plasma brain natriuretic peptide concentrations. Eur Heart J 2002;23:1379-86. Go to original source... Go to PubMed...
    62. Kettner J, Pirk J, Netuka I, et al. Mechanická podpora krevního oběhu - první zkušenosti v ČR. Čas Lék čes 2005;144:38-42.
    63. Keung EC, Siskind SJ, Sonneblick EH, et al. Dobutamine therapy in acute myocardial infarction. JAMA 1981; 245:144-6. Go to original source... Go to PubMed...
    64. Khand AU, Rankin AC, Kaye GC, et al. Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 2000;21:614-32. Go to original source... Go to PubMed...
    65. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967;20:457-64. Go to original source... Go to PubMed...
    66. Kitchen JB, Kastor JA. Pacing in acute myocardial infarction-indications, methods, hazards, and results. Cardiovasc Clin 1975;7:219-43. Go to PubMed...
    67. Kivikko M, Antila S, Eha J, et al. Pharmacokinetics of levosimendan and its metabolites during and after a 24 h continuous infusion in patients with severe heart failure. Int J Clin Pharmacol Ther 2002;40:465-71. Go to original source... Go to PubMed...
    68. Kivikko M, Lehtonen L, Colucci WS. Sustained hemodynamic effects of intravenous levosimendan. Circulation 2003;107:81-6. Go to original source... Go to PubMed...
    69. Krumholz HM, Parent EM, Tu N, et al. The treatment target in acute decompensated heart failure. Rev Cardiovasc Med 2001;2 (Suppl 2):S7-S12. Go to PubMed...
    70. Krumholz HM, Chen J, Murillo JE, et al. Admission to hospitals with on-site cardiac catheterization facilities: impact on long-term costs and autcomes. Circulation 1998;98:2010-6. Go to original source... Go to PubMed...
    71. Krumholz HM, Vaccarino V, Ellerbeck EF, al. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age. Am J Cardiol 1997; 79:581-6. Go to original source... Go to PubMed...
    72. Lainchbury JG, Campbell E, Frampton CM, et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728-35. Go to original source... Go to PubMed...
    73. Lee DC, Johnson RA, Bingham JB, et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med 1982;306:699-705. Go to original source... Go to PubMed...
    74. Lee G, DeMaria AN, Amsterdam EA, et al. Comparative effects of morphine, meperidine and pentazocine on cardiocirculatory dynamics in patients with acute myocardial infarction. Am J Med 1976;60:949-55. Go to original source... Go to PubMed...
    75. Leier CV, Binkley PF. Parenteral inotropic support for advanced congestive heart failure. Prog Cardiovasc Dis 1998;41:207-24. Go to original source... Go to PubMed...
    76. Liesching T, Kwok H, Hill NS. Acute applications of noninvasive positive pressure ventilation. Chest 2003;124: 699-713. Go to original source... Go to PubMed...
    77. Lin M, Yang YF, Chiang HT, et al. Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up. Chest 1995;107:1379-86. Go to original source... Go to PubMed...
    78. Lopez-Sendon J, Gonzales A, Lopez de Sa E, et al. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity a specificity of clinical, hemodynamic and echocardiographic criteria. J Am Coll Cardiol 1992;19:1145-53. Go to original source... Go to PubMed...
    79. Lowes BD, Tsvetkova T, Eichhorn EJ, et al. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol 2001;81:141-9. Go to original source... Go to PubMed...
    80. Málek F, Ignaszewski A. Nové léky pro terapii pokročilého srdečního selhání. Cor Vasa 2004;46:221-5.
    81. Marban E. Myocardial stunning and hibernation. The physiology behind the colloquialisms. Circulation 1991;83:681-8. Go to original source... Go to PubMed...
    82. Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003;349:1333-40. Go to original source... Go to PubMed...
    83. Masip J, Betbese AJ, Paez J, et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet 2000;356:2126-32. Go to original source... Go to PubMed...
    84. Maskin CS, Ocken S, Chadwick B, et al. Comparative systemic and renal effects of dopamine and angiotensin-converting enzyme inhibition with enalapril in patients with heart failure. Circulation 1985;72:846-52. Go to original source... Go to PubMed...
    85. McAlister FA, Lawson FM, Teo KK, et al. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 2001;110:378-84. Go to original source... Go to PubMed...
    86. McClement BM. Value of signal-averaged electrocardiography, radionuclide ventriculopathy, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1993;21:1419-27. Go to original source... Go to PubMed...
    87. McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart Failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002;39:60-9. Go to original source... Go to PubMed...
    88. McGhie Al, Goldstein RA. Pathogenesis and management of acute heart failure and cardiogenic shock: role of inotropic therapy. Chest 1992;102:6265-325. Go to original source... Go to PubMed...
    89. Mehta S, Jay GD, Woolard RH, et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Crit Care Med 1997;25:620-8. Go to original source... Go to PubMed...
    90. Mehta SM, Pae WE Jr, Rosenberg G, et al. The Lion Heart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg 2001;71:S156-S61. Go to original source... Go to PubMed...
    91. Menon V, Slater JN, White HD, et al. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med 2000;108:374-80. Go to original source... Go to PubMed...
    92. Meszaros WT. Cardiac Roentgenolgy: plain films and angiographic findings. Springfield: Charles Thomas Publishers, 1969.
    93. Meszaros WT. Lung changes in left heart failure. Circulation 1973;47:869-72. Go to original source... Go to PubMed...
    94. Metra M, Nodari S, D'Aloia A, et al. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure:a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol 2002;40:1248-58. Go to original source... Go to PubMed...
    95. Mueller H, Ayres SM, Giannelli S Jr, et al. Effect of isoproterenol, l-norepinephrine, and intraaortic counterpulzation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction. Circulation 1972;45:335-51. Go to original source... Go to PubMed...
    96. Mueller HS, Chatterjee K, Davis KB, et al. ACC expert consensus document. Present use of bedside right heart catheterization in patients with cardiac disease. J Am Coll Cardiol 1998;32:840-64. Go to original source... Go to PubMed...
    97. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335:1182-9. Go to original source... Go to PubMed...
    98. Neuberg GW, Miller AB, O'Connor CM, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 2002;144:31-8. Go to original source... Go to PubMed...
    99. Nieminen MS, Boehm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26: 383-416.
    100. Nieminen MS, Lilleberg J, Leikola-Pelho T, et al. Dose related responses of a new calcium-sensitizer, simendan, in man. Eur Heart J 1992;13:P1440.
    101. Nohria ATS, Fang JC, Lewis EF, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003;41:1797-804. Go to original source... Go to PubMed...
    102. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failue. JAMA 2002;287:628-40. Go to original source... Go to PubMed...
    103. O'Connell JB. The economic burden of heart failure. Clin Cardiol 2000;23:III6-III10. Go to original source... Go to PubMed...
    104. O'Connor CM, Gattis WA, Uretsky BF, et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999;138:78-86. Go to original source... Go to PubMed...
    105. Olaison L, Pettersson G. Current best practices and guidelines. Indications for surgical intervention in infective endocarditis. Cardiol Clin 2003;21:235-51. Go to original source... Go to PubMed...
    106. Pohjola-Sintonen S, Muller JE, Stone PH, et al. Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J 1989;117:809-18. Go to original source... Go to PubMed...
    107. Priori SG, Aliot E, Blomström-Lundqvist C, et al. Task Force on Sudden Cardiac Death, European Society of Cardiology. Europace 2002;4:3-18. Go to original source... Go to PubMed...
    108. Rahimtoola SH, Sinno MZ, Chuquimia R, et al. Effects of ouabain on impaired left ventricular function in acute myocardial infarction. N Engl J Med 1972;287:527-31. Go to original source... Go to PubMed...
    109. Rasanen J, Heikkila J, Downs J, et al. Continuous positive airway pressure by facemask in acute cardiogenic pulmonary edema. Am J Cardiol 1985;55:296-300. Go to original source... Go to PubMed...
    110. Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003;289:871-8. Go to original source... Go to PubMed...
    111. Ratshin RA, Rackley CE, Russel RO Jr. Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction. Circulation 1972;45: 127-39. Go to original source... Go to PubMed...
    112. Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocardial infarction. Br Med J 1976; 288:1121-3. Go to original source... Go to PubMed...
    113. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60. Go to original source... Go to PubMed...
    114. Rhodes A, Cusack RJ, Newman PJ, et al. A randomised, controlled trial of the pulmonary artery catheter in critically ill patients. Intens Care Med 2002;28:256-64. Go to original source... Go to PubMed...
    115. Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the randomisation of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5. Go to original source... Go to PubMed...
    116. Roguin A, Behar D, Ben Ami H, et al. Long-term prognosis of acute pulmonary oedema-an ominous outcome. Eur J Heart Fail 2000;2:137-44. Go to original source... Go to PubMed...
    117. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-43. Go to original source... Go to PubMed...
    118. Sackner-Bernstein JD, Kowalski M, Fox M, et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure. JAMA 2005;293: 1900-5. Go to original source... Go to PubMed...
    119. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005;111:1487-91. Go to original source... Go to PubMed...
    120. Samama MM, Cohen AT, Darmon JY, et al. A comparsion of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999;341:793-800. Go to original source... Go to PubMed...
    121. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon counterpulzation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000;36:1123-9. Go to original source... Go to PubMed...
    122. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulzation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000;36 (Suppl A):1123-9. Go to original source... Go to PubMed...
    123. Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5-14. Go to original source... Go to PubMed...
    124. Sharma A, Hermann DD, Mehta RL. Clinical benefit and approach of ultrafiltration in acute heart failure. Cardiology 2001;96:144-54. Go to original source... Go to PubMed...
    125. Sharpe N. Heart Failure Management. London: Martin Dunitz LTD, 2000:276. Go to original source...
    126. Sharon A, Shpirer I, Kaluski E, et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol 2000; 36:832-7. Go to original source... Go to PubMed...
    127. Sharpe N. Beta-blockers in heart failure. Future directions. Eur Heart J 1996;17 (Suppl B):39-42. Go to original source... Go to PubMed...
    128. Schulz R, Rose J, Martin C, et al. Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation 1993;88:684-95. Go to original source... Go to PubMed...
    129. Silver MA, Horton DP, Ghali JK, et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol 2002;39:798-803. Go to original source... Go to PubMed...
    130. Simon L, Gauvin F, Amre DK, et al. Serum prokalcitonin and C reaktive protein levels as markers of bacterial infection: a systematic review and metaanalysis. Clin Infect Dis 2004;39:206-17. Go to original source... Go to PubMed...
    131. Slawsky MT, Colucci WS, Gotlieb SS, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study investigators. Circulation 2000;102:2222-7. Go to original source... Go to PubMed...
    132. Sosin MD, Bhatia GS, Zarifis J, et al. An 8-year follow-up study of acute admissions with heart failure in a multiethnic population. Eur J Heart Failure 2004;6:669-72. Go to original source... Go to PubMed...
    133. Spargias AS, Hall AS, Ball SG. Safety concerns about digoxin after acute myocardial infarction. Lancet 1999;354:391-2. Go to original source... Go to PubMed...
    134. Sutton JSM, Pfeffer MA, Plappert T, et al. Quantitative two dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction, the protective effect of captopril. Circulation 1994;89:68-75. Go to original source... Go to PubMed...
    135. Stevenson LW, Kormos RL. Mechanical Cardiac Support 2000: Current applications and future trial design. J Thorac Cardiovasc Surg 2001;121:418-24. Go to original source... Go to PubMed...
    136. Stevenson R, Ranjadayalan K, Wilkinson P, et al. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. Br Med J 1993; 307:349-53. Go to original source... Go to PubMed...
    137. Stevenson LW, Massie BM, Francis GS. Optimizing therapy for complex or refractory heart failure: A management algorithm. Am Heart J 1998;135:S293-S309. Go to original source... Go to PubMed...
    138. Ševčík P, Černý V, Vítovec J, a spol. Intenzivní medicína, 2. vyd. Praha: Galen, 2003:422.
    139. Špinar J, Hradec J, Málek I, Toman J. Doporučení pro diagnostiku a léčbu chronického srdečního selhání. Cor Vasa 2001;6:K123-K138.
    140. Špinar J, Vítovec J. Betablokátory a závažné srdeční selhání. Cor Vasa 2000;42:491-4.
    141. Špinar J, Vítovec J. Ischemická choroba srdeční. Praha: Grada, 2003:360.
    142. Špinar J, Vítovec J. Normy pro BNP a NT-proBNP stanoveny. Cor Vasa 2005;47:395-8.
    143. Špinar J,Vítovec J, Blaha M, et al. Radiologic changes in chronic heart failure. Cor Vasa 1992;34:88-99.
    144. Task Force of the Working Group on Heart Failure of the European Society of Cardiology: The treatment of heart failure. Eur Heart J 1997;18:736-53. Go to original source... Go to PubMed...
    145. Tavakoli R, Weber A, Brunner-La Rocca H, et al. Results for surgery for irreversible moderate to severe mitral valve regurgitation secondary to myocardial infarction. Eur J Cardiothorac Surg 2002;21:818-24. Go to original source... Go to PubMed...
    146. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4. Go to original source... Go to PubMed...
    147. Thackray S, Easthaugh J, Freemantle N, et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure - a meta-regression analysis. Eur J Heart Fail 2002;4:515-29. Go to original source... Go to PubMed...
    148. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 3: adult basic life support. Circulation 2000;102:122-59.
    149. The MERIT HF investigators: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7. Go to original source...
    150. Thompson CR, Buller CE, Sleeper La, et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000;36:1104-9. Go to original source... Go to PubMed...
    151. Topol EJ. Nesiritide - Not Verified. N Engl J Med 2005; 353:113-6. Go to original source... Go to PubMed...
    152. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with SR-segment elevation. The Task force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24:28-66. Go to original source... Go to PubMed...
    153. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67. Go to original source... Go to PubMed...
    154. Vítovec J, Špinar J. Farmakoterapie kardiovaskulárních onemocnění. 2. vydání. Praha: Grada, 2004:248.
    155. Waksman R, Weiss AT, Gotsman MS, et al. Intra-aortic balloon counterpulzation improves survival in cardiogenic shock complicating acute myocardial infarction. Eur Heart J 1993;14:71-4. Go to original source... Go to PubMed...
    156. Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999;138:258-90. Go to original source... Go to PubMed...
    157. Widimský P, Janoušek S, Vojáček J. Doporučení pro diagnostiku a léčbu akutního infarktu myokardu (Q-typ//s elevacemi ST//s raménkovým blokem). Cor Vasa 2002; 44:K123-K143.
    158. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med 1998;339:173-81. Go to original source... Go to PubMed...
    159. Wilson J, Woods I, Fawcett J, et al. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. Br Med J 1999;318:1099-103. Go to original source... Go to PubMed...
    160. Witchitz S, Cohen-Solal A, Dartois N, et al. Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vazodilatory properties. The CELICARD Group. Am J Cardiol 2000;85:1467-71. Go to original source... Go to PubMed...
    161. Wong SC, Sanborn T, Sleeper LA, et al. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000;36:1077-83. Go to original source... Go to PubMed...
    162. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71. Go to original source... Go to PubMed...
    163. Zamorano J, Moreno R, Almeria C, et al. Left ventricular free wall rupture during dobutamine stress echocardiography. Rev Esp Cardiol 2002;55:312-4.
    164. Zion MM, Balkin J, Rosenmann D, et al. Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5,841 patients in the SPRINT Registry. SPRINT Study Group. Chest 1990;98:1331-5. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes